These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 29038276)

  • 1. Reduced Chlorhexidine and Daptomycin Susceptibility in Vancomycin-Resistant Enterococcus faecium after Serial Chlorhexidine Exposure.
    Bhardwaj P; Hans A; Ruikar K; Guan Z; Palmer KL
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlorhexidine Induces VanA-Type Vancomycin Resistance Genes in Enterococci.
    Bhardwaj P; Ziegler E; Palmer KL
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2209-21. PubMed ID: 26810654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilizing genomic analyses to investigate the first outbreak of vanA vancomycin-resistant Enterococcus in Australia with emergence of daptomycin non-susceptibility.
    Douglas AP; Marshall C; Baines SL; Ritchie D; Szer J; Madigan V; Chan HT; Ballard SA; Howden BP; Buising K; Slavin MA
    J Med Microbiol; 2019 Mar; 68(3):303-308. PubMed ID: 30663951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Oritavancin Dosing Strategies against Vancomycin-Resistant Enterococcus faecium Isolates with or without Reduced Susceptibility to Daptomycin in an
    Belley A; Arhin FF; Moeck G
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution and mutations predisposing to daptomycin resistance in vancomycin-resistant Enterococcus faecium ST736 strains.
    Wang G; Yu F; Lin H; Murugesan K; Huang W; Hoss AG; Dhand A; Lee LY; Zhuge J; Yin C; Montecalvo M; Dimitrova N; Fallon JT
    PLoS One; 2018; 13(12):e0209785. PubMed ID: 30576392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of daptomycin non-susceptibility in colonizing vancomycin-resistant Enterococcus faecium isolates during daptomycin therapy.
    Lellek H; Franke GC; Ruckert C; Wolters M; Wolschke C; Christner M; Büttner H; Alawi M; Kröger N; Rohde H
    Int J Med Microbiol; 2015 Dec; 305(8):902-9. PubMed ID: 26454536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid in vivo development of resistance to daptomycin in vancomycin-resistant Enterococcus faecium due to genomic alterations.
    Mollerup S; Elmeskov C; Pinholt M; Sejersen TS; Pedersen MS; Worning P; Frees D; Westh H
    FEMS Microbiol Lett; 2022 Aug; 369(1):. PubMed ID: 35922088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Daptomycin Dose Exposure Alone or in Combination with β-Lactams or Rifampin against Vancomycin-Resistant Enterococci in an
    Jahanbakhsh S; Singh NB; Yim J; Kebriaei R; Smith JR; Lev K; Tran TT; Rose WE; Arias CA; Rybak MJ
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094136
    [No Abstract]   [Full Text] [Related]  

  • 9. Institution-wide and Within-Patient Evolution of Daptomycin Susceptibility in Vancomycin-Resistant Enterococcus faecium Bloodstream Infections.
    Woods RJ; Patel TS; Nagel JL; Newton DW; Read AF
    Infect Control Hosp Epidemiol; 2018 Feb; 39(2):226-228. PubMed ID: 29331166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daptomycin susceptibility testing and therapeutic use in enterococcal bloodstream infection (EBSI) in a setting with high rates of vancomycin-resistant Enterococcus faecium (VREfm).
    Kelly J; Tysall L; Dewar S
    J Antimicrob Chemother; 2022 Apr; 77(5):1432-1435. PubMed ID: 35165738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of Enterococcus faecium in Response to a Combination of Daptomycin and Fosfomycin Reveals Distinct and Diverse Adaptive Strategies.
    Supandy A; Mehta HH; Tran TT; Miller WR; Zhang R; Xu L; Arias CA; Shamoo Y
    Antimicrob Agents Chemother; 2022 Jun; 66(6):e0233321. PubMed ID: 35543524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Pharmacodynamics of Single-Dose Oritavancin and Daily High-Dose Daptomycin Regimens against Vancomycin-Resistant Enterococcus faecium Isolates in an
    Belley A; Lalonde-Séguin D; Arhin FF; Moeck G
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small RNAs in vancomycin-resistant Enterococcus faecium involved in daptomycin response and resistance.
    Sinel C; Augagneur Y; Sassi M; Bronsard J; Cacaci M; Guérin F; Sanguinetti M; Meignen P; Cattoir V; Felden B
    Sci Rep; 2017 Sep; 7(1):11067. PubMed ID: 28894187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spread of Vancomycin-Resistant Enterococcus faecium Isolates Despite Validated Infection Control Measures in an Italian Hospital: Antibiotic Resistance and Genotypic Characterization of the Endemic Strain.
    Bressan R; Knezevich A; Monticelli J; Campanile F; Busetti M; Santagati M; Dolzani L; Milan A; Bongiorno D; Di Santolo M; Tonin EA; Stefani S; Luzzati R; Lagatolla C
    Microb Drug Resist; 2018 Oct; 24(8):1148-1155. PubMed ID: 29373085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Lactams enhance daptomycin activity against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium in in vitro pharmacokinetic/pharmacodynamic models.
    Smith JR; Barber KE; Raut A; Rybak MJ
    Antimicrob Agents Chemother; 2015 May; 59(5):2842-8. PubMed ID: 25753639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Exposure of Methicillin-Resistant Staphylococcus aureus to Polyhexanide
    Renzoni A; Von Dach E; Landelle C; Diene SM; Manzano C; Gonzales R; Abdelhady W; Randall CP; Bonetti EJ; Baud D; O'Neill AJ; Bayer A; Cherkaoui A; Schrenzel J; Harbarth S; François P
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2CS-CHX
    Duarte B; Pereira AP; Freitas AR; Coque TM; Hammerum AM; Hasman H; Antunes P; Peixe L; Novais C
    Appl Environ Microbiol; 2019 Dec; 85(23):. PubMed ID: 31562170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-genome analyses of Enterococcus faecium isolates with diverse daptomycin MICs.
    Diaz L; Tran TT; Munita JM; Miller WR; Rincon S; Carvajal LP; Wollam A; Reyes J; Panesso D; Rojas NL; Shamoo Y; Murray BE; Weinstock GM; Arias CA
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4527-34. PubMed ID: 24867964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Two-Component System ChtRS Contributes to Chlorhexidine Tolerance in Enterococcus faecium.
    Guzmán Prieto AM; Wijngaarden J; Braat JC; Rogers MRC; Majoor E; Brouwer EC; Zhang X; Bayjanov JR; Bonten MJM; Willems RJL; van Schaik W
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242664
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model.
    Hall Snyder A; Werth BJ; Barber KE; Sakoulas G; Rybak MJ
    J Antimicrob Chemother; 2014 Aug; 69(8):2148-54. PubMed ID: 24777900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.